Document is current
Any future updates will be listed below
-
Authors
Hosseini, Seyyed Mohammad https://orcid.org/0000-0002-0568-2667
Sohrabi-Ashlaghi, Ahmadreza https://orcid.org/0009-0005-7187-7939
Kolahi, Shahriar https://orcid.org/0000-0002-7490-1229
Azizi, Narges https://orcid.org/0000-0003-2464-2473
Borooghani, Hoda https://orcid.org/0009-0009-6310-6041
Gharaylou, Zeinab https://orcid.org/0000-0001-7238-2616
Raminfard, Samira https://orcid.org/0000-0001-9335-7524
Ghanaati, Hossein https://orcid.org/0000-0003-4107-9336
Abbastabar, Hedayat https://orcid.org/0000-0002-5713-4806
Jalali, Amir Hossein https://orcid.org/0000-0002-7674-225X
Shakiba, Madjid https://orcid.org/0000-0001-5935-5111
Ghavami, Nafiseh https://orcid.org/0000-0001-7053-0443
Firouznia, Kavous https://orcid.org/0000-0002-9201-8173
- License Information
-
More Information
Article History
Received: 12 June 2025
Accepted: 9 September 2025
First Online: 13 October 2025
Declarations
:
: The authors declare no competing interests.
: The current study included patients from the Parkinson’s Progression Markers Initiative (PPMI). The study was authorized by the regional ethics boards of the PPMI sites. All patients who agreed to join the trial submitted written informed consent.
: All authors have read and approved the final manuscript for this submission. We confirm that this submitted paper is original and has not been published elsewhere, nor is it currently under consideration for publication in any other journal.
